Breaking News
October 15, 2018 - Following a Tissue Sample
October 15, 2018 - Prisoners need drug and alcohol treatments but AA programs aren’t the answer
October 15, 2018 - Andrea Califano and Jordan Orange Elected to National Academy of Medicine
October 15, 2018 - The impending risk of African Swine Fever Virus
October 15, 2018 - Researchers develop comprehensive molecular atlas of postnatal mouse heart development
October 15, 2018 - ObsEva SA Presents Clinical Data from Phase III IMPLANT 2 Trial of Nolasiban in IVF at the American Society of Reproductive Medicine (ASRM) Annual Meeting
October 15, 2018 - Engineering teratoma-derived fibroblasts to enhance osteogenesis
October 15, 2018 - Lab study shows effectiveness of potential therapy for treatment-resistant hypothyroidism
October 15, 2018 - JCU study firms up association between diet and depression
October 15, 2018 - Researchers to study the use of CRISPR on human liver on-a-chip platform
October 15, 2018 - Sub-concussive impacts not associated with decline in neurocognitive function
October 15, 2018 - Researchers find potential treatment to halt premature labor and birth
October 15, 2018 - As U.S. suicides rates rise, Hispanics show relative immunity
October 15, 2018 - FDA Issues a Complete Response Letter to Acacia Pharma for Barhemsys
October 15, 2018 - Photoactive bacteria bait may help in fight against MRSA infections
October 15, 2018 - Increasing vigorous exercise reduces risk factors of type 2 diabetes, cardiovascular disease in children
October 15, 2018 - First-of-its-kind study to test a personalized vaccine in cancer patient
October 15, 2018 - Extension trial assesses benefit of switching from flash monitoring to RT-CGM for hypoglycemia
October 15, 2018 - Half of parents say young children are afraid of doctor’s visits
October 15, 2018 - Study shows how fingerprint-based drug screening works on the living and deceased
October 15, 2018 - Study reveals potential to monitor progression of Alzheimer’s disease by measuring brain antioxidant levels
October 15, 2018 - FDA Approves Xarelto to Reduce the Risk of Major Cardiovascular Events in Patients with Chronic Coronary Artery Disease (CAD) or Peripheral Artery Disease (PAD)
October 15, 2018 - Promising new therapeutic approach against Ebola virus identified
October 15, 2018 - Study unravels how cancer stem cells use normal genes in abnormal ways
October 15, 2018 - Healthcare systems fail to deliver at affordable prices finds report
October 15, 2018 - Intensive BP Therapy in Diabetes May Lower Risk for CV Events
October 15, 2018 - Muscle relaxants increase risk of respiratory complications
October 15, 2018 - Female birds become more promiscuous after hatchings fail in the first breeding attempt
October 15, 2018 - Humans occupied Madagascar thousands of years later than previously thought
October 15, 2018 - Is Kidney Dialysis Always Needed When Septic Shock Strikes?
October 15, 2018 - Study shows invasive lung cancer surgery can lead to long-term opioid use
October 15, 2018 - Sugar, a “sweet” tool to understand brain injuries
October 14, 2018 - King’s commemorates activities and research on World Arthritis Day
October 14, 2018 - Humana and VFW NY team up on Stop 22 initiative to increase awareness of veterans committing suicide
October 14, 2018 - Water fluoridation contributes to urinary fluoride levels in pregnant women in Canada
October 14, 2018 - Study of children in Romanian orphanages tells cautionary tale about family separation
October 14, 2018 - Previous Endologix AFX Safety Notice classified by FDA as Class I recall
October 14, 2018 - Legal scholars sound alarm on academies’ report about returning research results to participants
October 14, 2018 - UNIST selects six extraordinary scholars to be induced as ‘Rising-star Distinguished Professor’
October 14, 2018 - Scientists find new way to help asthmatics breathe more easily
October 14, 2018 - New ‘gag rule’ may adversely impact health care of pregnant women
October 14, 2018 - Rosacea – Genetics Home Reference
October 14, 2018 - When the fighting crosses the line
October 14, 2018 - New findings could benefit patients with triple-negative breast cancer
October 14, 2018 - UK Biobank provides wealth of information for further genetic studies
October 14, 2018 - KHN’s ‘What the Health?’ Falling premiums and rising political tensions
October 14, 2018 - Duvelisib Promising for Chronic Lymphocytic Leukemia, SLL
October 14, 2018 - Tailored drug cocktails offer hope to kids with aggressive brain tumors
October 14, 2018 - Common gene variants linked to migraine risk in African-American children
October 14, 2018 - Funding requests are being accepted by BlueCross BlueShield of Tennessee Community Trust
October 14, 2018 - Using pulsed electric fields in cancer therapy
October 14, 2018 - Major Childbirth Complications More Likely for Black Women
October 14, 2018 - Young cancer survivors at greater risk of mental health disorders
October 14, 2018 - Common herbicide compound could help fight hospital-acquired fungal infections
October 14, 2018 - Alterations in genes encoding proteins contribute to ADHD development
October 14, 2018 - New patient-centric website launched in Europe to empower people with chronic conditions
October 14, 2018 - Antimicrobial signaling molecule has lower activity against hepatitis C virus in most humans
October 14, 2018 - Genomic dark matter activity connects Parkinson’s and psychiatric diseases
October 14, 2018 - Cornell dots equipped with antibody fragments offer a new cancer weapon
October 14, 2018 - Addressing social and cultural factors is key to reducing burden of type 2 diabetes
October 14, 2018 - Study reveals why females age more slowly than males
October 14, 2018 - DNA vaccine shown to provide long-term protection from Ebola
October 14, 2018 - Gene therapy shown to remove core component of Parkinson’s disease
October 14, 2018 - Obamacare premiums dip for first time. Some call it a correction
October 14, 2018 - Scientists use haploid stem cells to produce mice with same-sex parents
October 14, 2018 - New transgenic mouse model sheds light on biological causes of Parkinson’s disease
October 14, 2018 - Halobetasol Propionate Lotion Shows Efficacy for Tx of Psoriasis
October 14, 2018 - Overweight pregnant women can safely cut calories, restrict weight gain
October 14, 2018 - Scientists find new way to predict obesity-related disease risk
October 14, 2018 - Lab Innovations to host new range of laboratory product launches in Birmingham
October 14, 2018 - Insilico to present advances in artificial intelligence at the Healthcare Innovation Summit Africa 2018
October 14, 2018 - Infant’s complex babble may predict later literacy skills
October 14, 2018 - Brain’s neurons are more changeable in adulthood than previously thought
October 14, 2018 - A-Fib Tied to Higher Odds for Dementia
October 14, 2018 - Just because you’re thin, it doesn’t mean you’re healthy
October 14, 2018 - Healthy gut microbiome shown to be important for recovery after heart attack
October 14, 2018 - Study shows no added benefit of pertuzumab combination in treatment of early breast cancer
October 14, 2018 - Research holds promise for treatment of pediatric brain cancer
October 14, 2018 - Smoking genes do not trigger heavier drinking, shows research
October 14, 2018 - Two major studies on canine cancers may provide clues on human cancers
EMBO’s long-term fellowships support advanced research by funding postdoctoral scientists

EMBO’s long-term fellowships support advanced research by funding postdoctoral scientists

image_pdfDownload PDFimage_print

Committed to scientific excellence, since the 1960s, the European Molecular Biology Organization (EMBO) has helped thousands of early-career scientists through its fellowship programme. Typically awarded for two-year periods, EMBO’s long-term fellowships support advanced research and training by funding postdoctoral scientists through spells in other European countries or, when justified, further afield.

Between 2001 and 2010, applications for EMBO fellowships more than doubled, creating a situation in which co-funding was needed to meet demand. Subsequently, the EMBO successfully applied for funding from the EU’s Marie Skłodowska-Curie Actions programme, leading to the establishment of its long-term fellowship co-fund, LTFCOFUND2013.

The fund has enabled the EMBO to increase the number of its transnational fellowships and improve fellowship conditions, thereby furthering the development of European research.

In 2015, from a total of 1 549 applications, the LTFCOFUND2013 was used to provide fellowships for 252 young postdoctoral life scientists (or EMBO fellows) during a crucial phase in their careers. This figure is about 25 % higher than that for 2016, when no co-funded money was available for the EMBO.

‘Through LTFCOFUND2013, EMBO funded early postdoctoral researchers in most areas of life sciences with a focus on molecular biology,’ says David del Álamo, head of the EMBO’s fellowships programme in Germany. ‘However, the EMBO defines molecular biology in the broadest possible terms, encompassing research into the mechanisms of life at all levels, from single molecules to organisms and ecosystems.’

The EMBO funds applications in areas as diverse as molecular biology of disease and biomedicine, neuroscience, plant biology, ecology and evolution, genomic and computational biology, and structural biology and biophysics, he adds.

Developing careers

Funding under LTFCOFUND2013 is only used to cover fellows’ needs. As del Álamo says: ‘No money is spent on overheads, research-related costs or any other administrative or bureaucratic expenses. The EMBO aims to maximise the investment in researchers themselves, helping them develop their careers and therefore advancing science in Europe and beyond.’

In terms of career development, EMBO fellows have the chance to attend lab leadership courses during their fellowship periods to help them move into group leader roles shortly afterwards.

A boost for science

As regards advancing science, EMBO funding helped enhance medical knowledge of the genetic changes and mutations associated with some 7 000 tumours across 19 types of human cancer. Another EMBO-funded study of 46 children and 30 adults in Sweden advanced knowledge of human brain development. This could feed into the development of treatments for neurological disorders such as autism, dyslexia and attention deficit hyperactivity disorder.

EMBO fellowships have also helped further understanding of areas including Alzheimer’s disease, heart conditions, injuries to the central nervous system, leukaemia, and breast, lung and kidney cancer.

At the end of their fellowship, all fellows are invited to the EMBO fellows’ meeting in Heidelberg, Germany. A similar gathering is organised every two years in the USA for fellows living in North America. According to del Álamo, this represents ‘an excellent opportunity not only to present their scientific results but also for networking with other fellows’.

Source:

http://ec.europa.eu/research/infocentre/article_en.cfm?id=/research/headlines/news/article_18_10_01_en.html?infocentre&item=Infocentre&artid=49695

Tagged with:

About author

Related Articles